Pharma Ally Kurt Schrader Cashes In on K Street
Schrader’s new lobbying employer works for numerous drug companies like Pfizer and Sanofi, plus industry trade association PhRMA.
2 posts with this tag
Scott Peters
Pharma Companies Spend Billions More on Stock Buybacks Than Developing Drugs, House Report Finds
The largest drugmakers spent $56 billion more on stock buybacks and dividends than on research and development from 2016 to 2020, according to a new House committee report.
